#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	9834	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2097	462.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1701	1701	T	514	T,C	483,9	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	9834	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2097	462.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1435	1435	C	524	C	514	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	17758	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3559	494.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1665	1665	A	569	A,G	548,11	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	17758	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3559	494.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2299	2299	C	565	C	545	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	17758	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3559	494.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2373	2373	A	569	A	553	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	17758	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3559	494.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2925	2925	C	553	C,T	542,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1242	folP	855	855	100.0	folP.l15.c4.ctg.1	1611	76.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1007	1009	AGC	117;116;117	A;G;C	115;114;114	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3776	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3503	106.8	1	SNP	p	S91F	1	.	.	271	273	TTC	668	670	TTC	136;135;133	T;T,C;C	133;132,1;130	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3776	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3503	106.8	1	SNP	p	G95N	0	.	.	283	285	GGC	680	682	GGC	129;128;126	G;G,A;C	126;124,1;124	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3776	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3503	106.8	1	SNP	p	D95G	1	.	.	283	285	GGC	680	682	GGC	129;128;126	G;G,A;C	126;124,1;124	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1114	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1265	87.3	1	SNP	p	G45D	0	.	.	133	135	GGC	449	451	GGC	127;128;128	G;G;C	125;126;126	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	634	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	916	68.7	0	.	n	.	0	A197.	DEL	197	197	A	542	542	A	146	A	141	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	2966	parC	2304	2304	99.87	parC.l15.c17.ctg.1	2869	102.0	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1409	1411	GTC	135;135;136	G;T;C	133;131;134	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	2966	parC	2304	2304	99.87	parC.l15.c17.ctg.1	2869	102.0	1	SNP	p	D86N	0	.	.	256	258	GAC	515	517	GAC	113;113;116	G;A;C	109;105;113	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	2966	parC	2304	2304	99.87	parC.l15.c17.ctg.1	2869	102.0	1	SNP	p	R87W	0	.	.	259	261	CGT	518	520	CGT	116;114;114	C,A;G;T	111,1;109;110	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	2966	parC	2304	2304	99.87	parC.l15.c17.ctg.1	2869	102.0	1	SNP	p	R87I	0	.	.	259	261	CGT	518	520	CGT	116;114;114	C,A;G;T	111,1;109;110	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	2966	parC	2304	2304	99.87	parC.l15.c17.ctg.1	2869	102.0	1	SNP	p	S87R	1	.	.	259	261	CGT	518	520	CGT	116;114;114	C,A;G;T	111,1;109;110	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	2966	parC	2304	2304	99.87	parC.l15.c17.ctg.1	2869	102.0	1	SNP	p	S88P	0	.	.	262	264	TCC	521	523	TCC	113;112;113	T;C;C	109;108;109	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	2658	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2705	97.2	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1435	1437	TGC	135;135;132	T,C;G;C	131,3;131;126	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	2658	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2705	97.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1645	1647	GGC	134;132;131	G;G,A;C	130;127,1;127	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	2742	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2156	124.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1170	1172	GCA	159;160;159	G,T;C;A,C	152,1;149;152,1	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	2742	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2156	124.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1173	1175	ATC	160;161;161	A;T;C,A,G	154;154;151,1,1	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	2742	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2156	124.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1185	1187	GTG	168;162;160	G,A;T,C;G,C	162,1;156,1;154,1	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	2742	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2156	124.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1185	1187	GTG	168;162;160	G,A;T,C;G,C	162,1;156,1;154,1	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	2742	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2156	124.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1689	1691	ACC	116;117;117	A,G;C;C	111,1;115;114	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	2742	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2156	124.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1743	1745	GCG	110;108;108	G;C,G;G	103;97,1;104	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	2742	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2156	124.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1743	1745	GCG	110;108;108	G;C,G;G	103;97,1;104	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	2742	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2156	124.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1866	1868	GGC	101;102;101	G;G;C,T	96;102;98,2	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	2742	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2156	124.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1875	1877	GGC	97;97;96	G,A;G;C,G	91,2;94;91,1	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	2742	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2156	124.5	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1893	1895	TCG	87;89;93	T,G,C;C,G;G,C	57,9,2;76,1;76,2	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	3890	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3218	119.4	0	.	p	.	0	E418G	NONSYN	1252	1254	GAG	1653	1655	GGG	121;120;121	G;G,A;G	109;111,3;116	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	3890	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3218	119.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1662	1664	CCG	122;121;121	C,T;C,T;G	114,1;116,1;113	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1484	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1788	81.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	523	523	C	106	C	105	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1810	porB1b	1047	1047	99.43	porB1b.l15.c30.ctg.1	1445	123.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	370	372	GAA	133;135;134	G;A;A	127;130;130	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1810	porB1b	1047	1047	99.43	porB1b.l15.c30.ctg.1	1445	123.5	0	.	p	.	0	N134D	NONSYN	400	402	AAT	658	660	GAT	144;146;146	G,A;A;T,G	141,1;144;143,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1810	porB1b	1047	1047	99.43	porB1b.l15.c30.ctg.1	1445	123.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	781	783	TCA	150;153;158	T;C,A;A	145;146,1;151	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1810	porB1b	1047	1047	99.43	porB1b.l15.c30.ctg.1	1445	123.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	910	912	GTC	160;157;158	G;T;C,G	157;151;155,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1810	porB1b	1047	1047	99.43	porB1b.l15.c30.ctg.1	1445	123.5	1	SNP	p	G120K	1	.	.	358	360	AAG	616	618	AAG	145;144;143	A;A;G	145;142;142	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1810	porB1b	1047	1047	99.43	porB1b.l15.c30.ctg.1	1445	123.5	1	SNP	p	D121N	0	.	.	361	363	GAC	619	621	GAC	143;141;143	G,A;A;C	141,1;138;141	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1810	porB1b	1047	1047	99.43	porB1b.l15.c30.ctg.1	1445	123.5	1	SNP	p	A121D	1	.	.	361	363	GAC	619	621	GAC	143;141;143	G,A;A;C	141,1;138;141	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6608	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4795	136.7	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1972	1974	AAT	129;129;129	A;A;T	128;127;128	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	766	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1184	63.8	1	SNP	p	V57M	1	.	.	169	171	ATG	555	557	ATG	166;167;166	A;T;G	162;162;160	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
